HomeCompareUSOD vs PFE

USOD vs PFE: Dividend Comparison 2026

USOD yields 32.52% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 USOD wins by $103.4K in total portfolio value
10 years
USOD
USOD
● Live price
32.52%
Share price
$6.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$152.9K
Annual income
$21,694.05
Full USOD calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — USOD vs PFE

📍 USOD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUSODPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, USOD + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
USOD pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

USOD
Annual income on $10K today (after 15% tax)
$2,764.23/yr
After 10yr DRIP, annual income (after tax)
$18,439.94/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $3,879.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of USOD + PFE for your $10,000?

USOD: 50%PFE: 50%
100% PFE50/50100% USOD
Portfolio after 10yr
$101.2K
Annual income
$23,976.38/yr
Blended yield
23.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

USOD
No analyst data
Altman Z
0.0
Piotroski
3/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

USOD buys
0
PFE buys
0
No recent congressional trades found for USOD or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUSODPFE
Forward yield32.52%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$152.9K$49.6K
Annual income after 10y$21,694.05$26,258.71
Total dividends collected$107.5K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: USOD vs PFE ($10,000, DRIP)

YearUSOD PortfolioUSOD Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$13,952$3,252.03$9,153$693.39+$4.8KUSOD
2$19,169$4,240.42$8,593$849.25+$10.6KUSOD
3$25,956$5,444.89$8,336$1,066.78+$17.6KUSOD
4$34,663$6,890.30$8,437$1,384.80+$26.2KUSOD
5$45,689$8,599.76$9,013$1,875.40+$36.7KUSOD
6$59,481$10,593.74$10,306$2,680.72+$49.2KUSOD
7$76,534$12,889.37$12,820$4,101.38+$63.7KUSOD
8$97,391$15,499.73$17,673$6,826.70+$79.7KUSOD
9$122,642$18,433.39$27,543$12,591.86+$95.1KUSOD
10$152,921$21,694.05$49,560$26,258.71+$103.4KUSOD

USOD vs PFE: Complete Analysis 2026

USODStock

The investment seeks the daily changes in percentage terms of its shares’ per share NAV to reflect three times the inverse of the daily change in percentage terms of the price of a specified short-term futures contract on light, sweet crude oil (the “Benchmark Oil Futures Contract”) less the fund’s expenses. USCF will endeavor to have the notional value of the fund’s aggregate short exposure to the Benchmark Oil Futures Contract at the close of each trading day approximately equal to 300% of the fund’s NAV. The Benchmark Oil Futures Contract is the futures contract on light, sweet crude oil as traded on the NYMEX, traded under the trading symbol “CL”.

Full USOD Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this USOD vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

USOD vs SCHDUSOD vs JEPIUSOD vs OUSOD vs KOUSOD vs MAINUSOD vs JNJUSOD vs MRKUSOD vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.